Product Details
PNC-27 Peptide: Targeted Cancer Therapy Research
PNC-27 is a synthetic peptide that has shown promise in cancer research due to its ability to selectively target and induce apoptosis in cancer cells. By binding to HDM-2, a protein that inhibits p53 tumor suppressor activity, PNC-27 helps restore the function of p53, leading to the targeted destruction of cancer cells while sparing healthy cells.
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C188H293N53O44S
- Molecular Weight: 4031.7 g/mol
Key Features:
- Targeted Cancer Therapy: Selectively induces apoptosis in cancer cells by targeting HDM-2.
- Restores p53 Function: Reactivates the tumor suppressor p53, promoting cancer cell death.
- Spares Healthy Cells: Minimizes damage to healthy cells, reducing potential side effects.
- Research-Backed: Supported by preliminary studies indicating its effectiveness in cancer research.
Conclusion:
PNC-27 stands out for its targeted approach in cancer therapy research. With ongoing studies, its role in selectively inducing cancer cell apoptosis continues to be illuminated. Ideal for laboratory and clinical research, PNC-27 offers a promising tool for exploring new frontiers in cancer treatment.
Important Notice: This product is intended as a research chemical only. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.
COA Batch PNC-0524-10 (10mg)
Batch PNC-0524-10
